Integrative Oncology
Natural Complementary Therapies for Cancer Care
Natural alternative therapies with analgesic, anti-inflammatory, and immunostimulant properties that relieve cancer symptoms and extend survival.
How We Work
Stage 3–4 cancer support
Immunostimulant therapies
Pain management
Quality of life improvement
Nutritional oncology support
Psychological support
Begin Your Journey to Recovery
Send your medical history and reports, and our specialists will evaluate your case and recommend a personalized treatment plan tailored to your needs.
Request a ConsultationWhatsAppOur Medical Programs at a Glance
Compare focus, key therapies, typical stay and ideal candidates across our main programs.
| Program | Primary Focus | Key Therapy / Innovation | Typical Stay | Care Setting | Best For |
|---|---|---|---|---|---|
| Integrative Oncology | Advanced & metastatic cancer support | CIMAvax-EGF®, VAXIRA®, HEBERSaVax®, VIDATOX® | 2–4 weeks | Inpatient & outpatient | Stage 3–4 cancer patients |
| Physical Rehabilitation | Neurological, orthopedic & cardiopulmonary recovery | NeuralCIM®, advanced physiotherapy | 3–6 weeks | Inpatient intensive | Stroke, TBI, post-surgery recovery |
| Diabetic Foot Treatment | Diabetic foot ulcer & limb salvage | Heberprot-P®, advanced wound care | 2–6 weeks | Inpatient & outpatient | Diabetic ulcers, gangrene risk |
| Early Vascular Detection | Early vascular risk detection | Non-invasive vascular screening | 2–5 days | Outpatient screening | Preventive cardiovascular screening |
| Hemodialysis on Vacation | Continued renal care during travel | Modern hemodialysis + nephrology team | Per session / ongoing | Outpatient dialysis suite | Dialysis patients visiting Cuba |
| Ayurvedic Medicine | Holistic detox & chronic disease support | Panchakarma, herbal medicine, yoga | 2–3 weeks | Residential wellness | Stress, chronic conditions, detox |
| Quality of Life | Preventive health & wellness assessment | Screening, lifestyle planning | 3–7 days | Outpatient assessment | Health-conscious adults, executive check-ups |
| Addiction Treatment | Substance & behavioral addiction recovery | Detox, psychiatric & behavioral therapy | 4–8 weeks | Inpatient nature retreat | Substance & behavioral addictions |
Stays are typical estimates; your personalized plan is confirmed after medical consultation.
Medical Evaluation Process
A clear, structured process guides you from first contact through to the completion of treatment.
1. Initial Consultation Request
Submit your medical records and treatment inquiry through our secure online consultation form. Our international patient coordinators review your case within 24 hours.
2. Specialist Medical Review
A board-certified specialist in the relevant discipline reviews your diagnosis, imaging, and laboratory results to determine suitability for the program.
3. Personalized Treatment Plan
Based on the review, our medical team develops an individualized treatment protocol with detailed timelines, therapies, and estimated costs.
4. Travel & Accommodation Coordination
Our concierge team handles visa support letters, flight coordination, airport transfers, and accommodation in partner hotels near the health center.
5. On-Arrival Assessment & Treatment
Upon arrival, a final in-person assessment confirms the plan. Treatment begins under continuous multidisciplinary medical supervision.
Treatment Duration
Treatment duration varies by program and individual patient needs. Most international medical programs at La Pradera range from 2 to 6 weeks, allowing sufficient time for comprehensive assessment, therapeutic intervention, and recovery monitoring. Your personalized treatment plan will include a precise estimated timeline after the specialist medical review.
Patient Eligibility
- Adults (18+) with a confirmed medical diagnosis appropriate for the selected program
- Completed medical records including recent imaging and laboratory results
- Medical clearance for international travel
- No uncontrolled acute conditions that would prevent safe treatment
- Willingness to comply with the prescribed treatment protocol and follow-up schedule
- Valid passport and ability to obtain a Cuban medical visa (support letter provided)
Why Choose Cuba for Medical Treatment
Accredited by Cuba's Ministry of Public Health (MINSAP)
Decades of experience treating international patients from over 40 countries
Pioneering Cuban biotechnology: CIMAvax-EGF®, Heberprot-P®, NeuralCIM®
Transparent, all-inclusive pricing with no hidden fees
Frequently Asked Questions
How do I begin my medical treatment in Cuba?
Begin by submitting a consultation request through our online form. Our international patient coordinators will review your medical records and connect you with the appropriate specialist within 24 hours to develop a personalized treatment plan.
Do I need a visa to travel to Cuba for medical treatment?
Yes. International patients require a Cuban medical visa. La Pradera provides an official invitation letter once your treatment plan is confirmed, which you submit with your visa application at the Cuban consulate in your country.
Is the treatment at La Pradera covered by international health insurance?
Coverage depends on your insurance provider and policy. We recommend contacting your insurer before travel. La Pradera provides detailed medical reports and invoices that you can submit for reimbursement. Direct payment options are also available.
What language support is available for international patients?
Our international patient services team provides interpretation in English, Spanish, Arabic, French, Russian, Turkish, and other languages. Medical consultations are conducted with professional interpreters to ensure clear communication throughout your treatment.
Can a family member or companion accompany me during treatment?
Yes. We encourage patients to travel with a companion. Accommodation can be arranged for family members in nearby partner hotels, and our concierge team assists with their travel and stay arrangements.
Explore Other Programs
Physical Rehabilitation
Comprehensive, intensive, and personalized physical rehabilitation for children and adults with neur
Learn moreQuality of Life
Disease prevention and early detection through personalized health assessments. We promote beneficia
Learn moreAyurvedic Medicine
The 'Science of Life' — ancestral wisdom with over 5,000 years of application. Therapies restore bal
Learn moreHemodialysis on Vacation
Enjoy your vacation in Cuba without interrupting hemodialysis treatment. Full medical support ensure
Learn moreCancer Types We Treat
Detailed information about specific conditions treated within our program.
Overview
Lung cancer is one of the most common and serious types of cancer worldwide. La Pradera offers treatment with CIMAvax-EGF®, the world's first therapeutic vaccine for non-small-cell lung cancer (NSCLC), developed by Cuba's Center of Molecular Immunology (CIM). Unlike preventive vaccines, CIMAvax-EGF® stimulates the patient's immune system to produce antibodies against epidermal growth factor (EGF), depriving cancer cells of the protein they need to multiply and grow.
Who Can Benefit
Adults diagnosed with stage IIIB or IV non-small-cell lung cancer (NSCLC) who have completed or are completing first-line oncology treatment (chemotherapy or radiotherapy). The vaccine is used as maintenance therapy to help control tumor growth and extend survival.
Procedure
After eligibility assessment, patients receive a series of intramuscular injections of CIMAvax-EGF® over a structured treatment protocol. The regimen begins with an induction phase of 5 doses in the first month, followed by monthly maintenance injections. Treatment is administered under continuous medical supervision with regular imaging and blood work to monitor response.
Advantages
- Stimulates the body's own immune system to target cancer cells
- Low toxicity profile compared to conventional chemotherapy
- Outpatient administration — no hospitalization required for each dose
- Improves quality of life during maintenance phase
- Developed by Cuba's Center of Molecular Immunology with over a decade of clinical use
Contraindications
Not suitable for patients with small-cell lung cancer (SCLC), pregnant or breastfeeding women, patients with active autoimmune diseases, or those with severe uncontrolled medical conditions. A full medical evaluation determines eligibility.
Expected Results
Clinical studies indicate that CIMAvax-EGF® can slow disease progression and improve survival in eligible patients, particularly those with high EGF levels. Results vary by individual; the medical team provides a personalized prognosis after reviewing each case.
Cuban Medical Innovations
Medical Programs · La Pradera
CIMAvax-EGF®
Therapeutic vaccine for non-small-cell lung cancer. Induces immune response against EGF to slow tumor growth.
VAXIRA®
Therapeutic cancer vaccine developed by Cuban and Argentine scientists to help the immune system recognize lung cancer cells.
HEBERSaVax®
New therapeutic cancer vaccine developed by the CIGB. Stimulates the immune system to recognize and attack tumor cells.
VIDATOX® 30CH
Homeopathic medicine from blue scorpion venom (Rhopalurus junceus). Used as a complementary supportive therapy for cancer patients.
Scientific References
- 1Rodríguez PC, et al. CIMAvax-EGF immunotherapy in advanced non-small cell lung cancer: Survival and immune response. Clinical Cancer Research.Source: Center of Molecular Immunology (CIM)View reference
- 2Rodríguez PC, et al. CIMAvax-EGF: A novel therapeutic vaccine for non-small-cell lung cancer. Journal of Clinical Oncology.Source: Center of Molecular Immunology (CIM), Havana, CubaView reference
- 3Berlanga Acosta J, et al. Heberprot-P: Recombinant human epidermal growth factor for diabetic foot ulcers. International Wound Journal.Source: Center for Genetic Engineering and Biotechnology (CIGB), Havana, CubaView reference
- 4Cuban Ministry of Public Health (MINSAP). National Health Statistics Annual Report.Source: Ministry of Public Health of CubaView reference
We use cookies to improve your experience and analyze traffic. By continuing, you agree to our use of cookies. Privacy Policy